Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) EBT Margin (2016 - 2025)

Medifast (MED) has disclosed EBT Margin for 16 consecutive years, with 8.5% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 957.0% year-over-year to 8.5%, compared with a TTM value of 1.46% through Dec 2025, down 209.0%, and an annual FY2025 reading of 1.46%, down 209.0% over the prior year.
  • EBT Margin was 8.5% for Q4 2025 at Medifast, down from 2.97% in the prior quarter.
  • Across five years, EBT Margin topped out at 15.56% in Q2 2021 and bottomed at 8.5% in Q4 2025.
  • Average EBT Margin over 5 years is 7.08%, with a median of 10.19% recorded in 2022.
  • The sharpest move saw EBT Margin tumbled -1953bps in 2024, then soared 904bps in 2025.
  • Year by year, EBT Margin stood at 12.37% in 2021, then fell by -22bps to 9.61% in 2022, then crashed by -47bps to 5.13% in 2023, then crashed by -79bps to 1.07% in 2024, then crashed by -894bps to 8.5% in 2025.
  • Business Quant data shows EBT Margin for MED at 8.5% in Q4 2025, 2.97% in Q3 2025, and 2.72% in Q2 2025.